Google
 
Google

World Stem Cell Summit 2010

Sunday, July 27, 2008

Life extension by inhibiting pregnancy protein

 

View this message online

Dear manoj kumar valluru,

Last week a patent (#7,402,724) was issued for a screening system to find agents that extent life-span, the screening system involving finding compounds or nucleic acids that inhibit the pregnancy associated plasma protein (PAPP-A). Why this is interesting is that animals lacking PAPP-A or having mutations in it live up to 30% longer as compared to wild-type controls. Given that similar life extension related patents (#7,345,178) have commanded high market valuations, this will be interesting to follow.

Another patent (#7,402,567) issued last week of relevance our field dealt with STIMULATION of apoptosis as a means of treating liver failure. The idea being that if you selectively kill the stellate cells, then they can no longer deposit collagen, and thus fibrosis will be ameliorated.

With exception of Osiris, who appears to be focusing on the immune modulatory uses of mesenchymal stem cells, few people are actually studying mechanisms by which mesenchymal stem cells actually mediate changes in the immune system. A paper published last week described that mesenchymal stem cells have in vitro activity against homeostatic, T cell receptor independent proliferation. This is a very powerful finding if reproducible in vivo.

Another publication of interest described the potential of clearing small, subcellular particles called exosomes from circulation of cancer patients as a means of restoring immunological activity.

 


Longevity and PAPP-A
 
 
Patent Number: 7,402,724

Pregnancy associated plasma protein-A (PAPP-A) is a protease that cleaves insulin-like growth factor binding-protein (IGFBP-4). PAPP-A is used experimentally as a diagnostic for myocardial infarction and also is indicative of various congenital abnormalities in utero.

Interestingly, if PAPP-A is knocked out or functionally inactivated...[Read More]

Ask a question OR leave your comments.

 


  Mesenchymal Stem Cells Inhibiting Homeostatic Proliferation

Friday July 25th, 2008 @ 20:50:32 EST

Felix Platter -Spital, Switzerland - 

Immune regulatory effects of mesenchymal stem cells include suppression of allogeneic lymphocyte proliferation, stimulation of T regulatory cells, and secretion of soluble immune suppressive molecules such as [Read More]

2 Comments

Ask a question OR leave your comments.

Read more StemCellPatents.com News
 


  NEWS - WHAT'S GETTING ATTENTION?  
  Mesenchymal Stem Cells Inhibiting Homeostatic Proliferation | 2 Comment(s)
 

 

wscs_440x600_opt_585

StemCellPatents.com is proud to be a supporter of the 2008 World Stem Cell Summit (www.worldstemcellsummit.com).

 


  RECENTLY ADDED PATENTS  
  Treatment of disease by inducing cell apoptosis (7,402,567)
Assignee | Inventor | Ask a question OR leave your comments
 
  Longevity and PAPP-A (7,402,724)
Assignee | Inventor | Ask a question OR leave your comments
 
  Production of a biological factor and creation of an immunologically privileged environment using genetically altered Sertoli cells (7,399,751)
Assignee | Inventor | Ask a question OR leave your comments
 
  Poly-Glu,Tyr for neuroprotective therapy (7,399,740)
Assignee | Inventor | Ask a question OR leave your comments
 
  Stem cell-specific promoters and their use (7,396,680)
Assignee | Inventor | Ask a question OR leave your comments
 
  Cell delivery patch for myocardial tissue engineering (7,396,537)
Assignee | Inventor | Ask a question OR leave your comments
 
  Method for enriching adherent monocyte populations (7,393,628)
Assignee | Inventor | Ask a question OR leave your comments
 
  Prolactin induced increase in neural stem cell numbers (7,393,830)
Assignee | Inventor | Ask a question OR leave your comments
 
  Optimization of immunomodulatory properties of genetic vaccines (7,390,619)
Assignee | Inventor | Ask a question OR leave your comments
 
  Self-contained adipose derived stem cell processing unit (7,390,484)
Assignee | Inventor | Ask a question OR leave your comments
 
  View all 1313 Stem Cell Patents on StemCellPatents.com  


  LATEST NEWS  
  Mesenchymal Stem Cells Inhibiting Homeostatic Proliferation
2 days ago : 2 Comments
 
  Clinical Trial of CD34 Stem Cells for Liver Failure
July 20th
 
  Interferon gamma as a "danger signal"
July 13th
 
  Liquid tumors need blood
July 9th
 
  4-1BB inhibits myelopoiesis/dendritic cell generation
July 9th
 
  Read more news on StemCellPatents.com  


  LATEST JOBS POSTS  
  Research Assistant
UAE University
 
  Patent Proscecution Technology Specialist or Scientific Advisor
Crescent Strategic Resources
 
  Attorney- Patent Litigation Associate
Crescent Strategic Resources
 
  View the StemCellPatents.com Job Board

 

 

Thanks again for your help in supporting StemCellPatents.com.


We welcome your comments! Tell us here.

Get the word out.






------------------------------------------------------------
To unsubscribe, click here.
Delivered: Monday July 28th, 2008 @ 00:17:36 EST
 
Google

Any Comments ?.......

E-mail: manojhind2001us@gmail.com
Google
 

World Time